Today's Updates

Adjuvant Belzutifan Combo Is ‘Practice Changing’ in RCC
Published Date: 05 Mar 2026

Adding belzutifan to standard adjuvant pembrolizumab cut the risk for recurrence or death in patients with resected clear cell renal cell carcinoma.

Read More

Latest News


Latest News

News All Time


Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Breast cancer: Why it's difficult to treat and what new approaches are on the horizon

2.

Formaldehyde releasers found in common personal care products used especially by Black and Latina women

3.

Novel Treatment Shows Promise for Oral Mucositis Caused by Radiation.

4.

AI could help improve early detection of interval breast cancers

5.

Integrative palliative care is critical to improving mental health among pancreatic cancer patients



© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot